Cargando…
Perspectives on preparing for long-acting injectable treatment for HIV among consumer, clinical and nonclinical stakeholders: A qualitative study exploring the anticipated challenges and opportunities for implementation in Los Angeles County
Long-acting injectable (LAI) antiretroviral therapy (ART) is a novel HIV treatment option for people with HIV. The first LAI ART regimen for HIV treatment received regulatory approval in the United States in January 2021. In February 2020, we collected qualitative data from 18 consumers and 23 clini...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812879/ https://www.ncbi.nlm.nih.gov/pubmed/35113892 http://dx.doi.org/10.1371/journal.pone.0262926 |
_version_ | 1784644748594642944 |
---|---|
author | Jolayemi, Oluwadamilola Bogart, Laura M. Storholm, Erik D. Goodman-Meza, David Rosenberg-Carlson, Elena Cohen, Rebecca Kao, Uyen Shoptaw, Steve Landovitz, Raphael J. |
author_facet | Jolayemi, Oluwadamilola Bogart, Laura M. Storholm, Erik D. Goodman-Meza, David Rosenberg-Carlson, Elena Cohen, Rebecca Kao, Uyen Shoptaw, Steve Landovitz, Raphael J. |
author_sort | Jolayemi, Oluwadamilola |
collection | PubMed |
description | Long-acting injectable (LAI) antiretroviral therapy (ART) is a novel HIV treatment option for people with HIV. The first LAI ART regimen for HIV treatment received regulatory approval in the United States in January 2021. In February 2020, we collected qualitative data from 18 consumers and 23 clinical and non-clinical stakeholders to catalog anticipated individual-consumer, healthcare system, and structural levels barriers and facilitators to LAI ART implementation in Los Angeles County, California. Thematic analysis was guided by the CFIR implementation science model. CFIR constructs of intervention characteristics, individual characteristics, outer and inner setting, intervention characteristics, and implementation process emerged in analysis. Under intervention characteristics, anticipated facilitators included the relative advantage of LAI ART over pills for adherence and reduced treatment management burden and related anxiety; anticipated barriers included non-adherence to injection appointments, concerns of developing HIV resistance, discomfort with injection and cost. Anticipated facilitators based on individual characteristics included overall acceptability based on knowledge and positive beliefs about LAI ART. Participant noted several characteristics of the outer setting that could negatively impact implementation, such as medical mistrust, external policies, and LAI ART eligibility (i.e., to be virally suppressed prior to initiation). Participants were optimistic about the potential to decrease stigma but expressed that provider willingness for adoption could be hindered by challenges in organizational inner setting related to payment authorizations, increased staffing needs, medication procurement and storage, and provider and healthcare system readiness. Results from this pre-implementation study may inform rollout and scale-up of LAI ART in Los Angeles County. |
format | Online Article Text |
id | pubmed-8812879 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-88128792022-02-04 Perspectives on preparing for long-acting injectable treatment for HIV among consumer, clinical and nonclinical stakeholders: A qualitative study exploring the anticipated challenges and opportunities for implementation in Los Angeles County Jolayemi, Oluwadamilola Bogart, Laura M. Storholm, Erik D. Goodman-Meza, David Rosenberg-Carlson, Elena Cohen, Rebecca Kao, Uyen Shoptaw, Steve Landovitz, Raphael J. PLoS One Research Article Long-acting injectable (LAI) antiretroviral therapy (ART) is a novel HIV treatment option for people with HIV. The first LAI ART regimen for HIV treatment received regulatory approval in the United States in January 2021. In February 2020, we collected qualitative data from 18 consumers and 23 clinical and non-clinical stakeholders to catalog anticipated individual-consumer, healthcare system, and structural levels barriers and facilitators to LAI ART implementation in Los Angeles County, California. Thematic analysis was guided by the CFIR implementation science model. CFIR constructs of intervention characteristics, individual characteristics, outer and inner setting, intervention characteristics, and implementation process emerged in analysis. Under intervention characteristics, anticipated facilitators included the relative advantage of LAI ART over pills for adherence and reduced treatment management burden and related anxiety; anticipated barriers included non-adherence to injection appointments, concerns of developing HIV resistance, discomfort with injection and cost. Anticipated facilitators based on individual characteristics included overall acceptability based on knowledge and positive beliefs about LAI ART. Participant noted several characteristics of the outer setting that could negatively impact implementation, such as medical mistrust, external policies, and LAI ART eligibility (i.e., to be virally suppressed prior to initiation). Participants were optimistic about the potential to decrease stigma but expressed that provider willingness for adoption could be hindered by challenges in organizational inner setting related to payment authorizations, increased staffing needs, medication procurement and storage, and provider and healthcare system readiness. Results from this pre-implementation study may inform rollout and scale-up of LAI ART in Los Angeles County. Public Library of Science 2022-02-03 /pmc/articles/PMC8812879/ /pubmed/35113892 http://dx.doi.org/10.1371/journal.pone.0262926 Text en https://creativecommons.org/publicdomain/zero/1.0/This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication. |
spellingShingle | Research Article Jolayemi, Oluwadamilola Bogart, Laura M. Storholm, Erik D. Goodman-Meza, David Rosenberg-Carlson, Elena Cohen, Rebecca Kao, Uyen Shoptaw, Steve Landovitz, Raphael J. Perspectives on preparing for long-acting injectable treatment for HIV among consumer, clinical and nonclinical stakeholders: A qualitative study exploring the anticipated challenges and opportunities for implementation in Los Angeles County |
title | Perspectives on preparing for long-acting injectable treatment for HIV among consumer, clinical and nonclinical stakeholders: A qualitative study exploring the anticipated challenges and opportunities for implementation in Los Angeles County |
title_full | Perspectives on preparing for long-acting injectable treatment for HIV among consumer, clinical and nonclinical stakeholders: A qualitative study exploring the anticipated challenges and opportunities for implementation in Los Angeles County |
title_fullStr | Perspectives on preparing for long-acting injectable treatment for HIV among consumer, clinical and nonclinical stakeholders: A qualitative study exploring the anticipated challenges and opportunities for implementation in Los Angeles County |
title_full_unstemmed | Perspectives on preparing for long-acting injectable treatment for HIV among consumer, clinical and nonclinical stakeholders: A qualitative study exploring the anticipated challenges and opportunities for implementation in Los Angeles County |
title_short | Perspectives on preparing for long-acting injectable treatment for HIV among consumer, clinical and nonclinical stakeholders: A qualitative study exploring the anticipated challenges and opportunities for implementation in Los Angeles County |
title_sort | perspectives on preparing for long-acting injectable treatment for hiv among consumer, clinical and nonclinical stakeholders: a qualitative study exploring the anticipated challenges and opportunities for implementation in los angeles county |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812879/ https://www.ncbi.nlm.nih.gov/pubmed/35113892 http://dx.doi.org/10.1371/journal.pone.0262926 |
work_keys_str_mv | AT jolayemioluwadamilola perspectivesonpreparingforlongactinginjectabletreatmentforhivamongconsumerclinicalandnonclinicalstakeholdersaqualitativestudyexploringtheanticipatedchallengesandopportunitiesforimplementationinlosangelescounty AT bogartlauram perspectivesonpreparingforlongactinginjectabletreatmentforhivamongconsumerclinicalandnonclinicalstakeholdersaqualitativestudyexploringtheanticipatedchallengesandopportunitiesforimplementationinlosangelescounty AT storholmerikd perspectivesonpreparingforlongactinginjectabletreatmentforhivamongconsumerclinicalandnonclinicalstakeholdersaqualitativestudyexploringtheanticipatedchallengesandopportunitiesforimplementationinlosangelescounty AT goodmanmezadavid perspectivesonpreparingforlongactinginjectabletreatmentforhivamongconsumerclinicalandnonclinicalstakeholdersaqualitativestudyexploringtheanticipatedchallengesandopportunitiesforimplementationinlosangelescounty AT rosenbergcarlsonelena perspectivesonpreparingforlongactinginjectabletreatmentforhivamongconsumerclinicalandnonclinicalstakeholdersaqualitativestudyexploringtheanticipatedchallengesandopportunitiesforimplementationinlosangelescounty AT cohenrebecca perspectivesonpreparingforlongactinginjectabletreatmentforhivamongconsumerclinicalandnonclinicalstakeholdersaqualitativestudyexploringtheanticipatedchallengesandopportunitiesforimplementationinlosangelescounty AT kaouyen perspectivesonpreparingforlongactinginjectabletreatmentforhivamongconsumerclinicalandnonclinicalstakeholdersaqualitativestudyexploringtheanticipatedchallengesandopportunitiesforimplementationinlosangelescounty AT shoptawsteve perspectivesonpreparingforlongactinginjectabletreatmentforhivamongconsumerclinicalandnonclinicalstakeholdersaqualitativestudyexploringtheanticipatedchallengesandopportunitiesforimplementationinlosangelescounty AT landovitzraphaelj perspectivesonpreparingforlongactinginjectabletreatmentforhivamongconsumerclinicalandnonclinicalstakeholdersaqualitativestudyexploringtheanticipatedchallengesandopportunitiesforimplementationinlosangelescounty |